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Introduction
Listeriolysin O (LLO) is a cholesterol-
dependent cytolysin (CDC) secreted by
the foodborne, facultative intracellular
pathogen Listeria monocytogenes. This
toxin is released in the extracellular and
intracellular environments, from where
it binds to cholesterol on host cell
membranes to form pores, facilitating
disease development. Among the
numerous members of the CDC family,
LLO displays unique properties, such
as temperature and pH sensitivity.
Results
Figure 1. LLO	  was	  incubated	   in	  PBS	  at	  37℃ for	  the	  indicated	  times	  and	  concentrations.	  At	  the	  
indicated	  time	  points,	  the	  tubes	  were	  transferred	  to	  ice,	  and	  the	  toxin	  was	  serially	  diluted	  in	  
PBS	  in	  a	  96	  well	  round	  bottom	  plate	  of	  10	  ul toxin	  and	  150	  ul RBCs	  (50	  nM and	  5	  nM);	  80	  ul
toxin	  and	  80	  ul RBCs	  (0.5	  nM)	  added	  on	  the	  ice.	  The	  plates	  were	  then	  incubated	  at	  37	  ℃ for	  
30	  min.	  Plates	  were	  centrifuged	  at	  1500	  rmp for	  5	  min.	  100	  ul of	  supernatant	  was	  transferred	  
to	  96	  flat	  bottom	  plates	  for	  optical	  density	  	  reading	  at	  540	  nm.	  Positive	  control:	  RBCs	  
incubated	  with	  10	  ul 1%	  TX-­‐100	  used	  to	  determine	  100%	  lysis. Negative	  control:	  RBCs	  
incubated	  with	  10	  ul PBS	  used	  to	  determine	  0%	  lysis
Identifying an animal model to study the role of extracellular 
listeriolysin O 
Based upon my preliminary experiments, human serum inhibits PLY to a higher extent 
than murine serum (figure 3 and 4). The result shows the mice sera don’t have inhibited 
ability for pneumolysin. I could not reproduce the data that were published on 
pneumolysin either. My hypothesis of this result is mice is not natural host for the 
pathogen. So it is reasonable that mice cannot inhibit toxin. In addition, I didn’t use the 
same method with Tweten’s. The purity of PLY, which I used, may be different with 
Tweten’s. Higher purity toxin has higher toxicity. It is hard to inhibit toxin if the 
toxicity is much higher. Next, I tested toxin LLO to see whether it have same result
with PLY.
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At neutral pH and temperatures above 30℃, LLO undergoes denaturation. The 
kinetic of LLO inactivation at 37°C (PH 7.4) has not been established. 
Additionally, a recent study proposed that in comparison to human serum, 
murine serum highly inactivates another CDC family member, pneumolysin
(PLY) produced by the bacterial pathogen Streptococcus pneumoniae. If this 
toxin-inhibitory property of murine serum also applies to LLO, this would imply 
that the murine model for L. monocytogenes infection is not appropriate to study 
the extracellular functions of LLO. The first goal of my work is to establish the 
kinetic curve model for different concentrations of LLO at 37℃ and neutral pH.
The second goal is to determine the relative inhibitory activity of sera obtained 
from various animal species in comparison to human sera in order to establish 
which animal models would be best to study LLO extracellular activities.
LLO activity is known to be temperature and pH sensitive.  At neutral pH (pH = 
7.4) and at a temperature above 30℃, LLO starts to denature and lose activity.   
In order to further characterize the hemolytic activity of LLO, I set up 3 
different concentrations of LLO: 50 nM, 5 nM and 0.5 nM. The curves of 5 nM
and 0.5 nM do not differ greatly.  
Adapted from Tilney and Portnoy. J. Cell. Biol.  1989
Establish the kinetic curve model for different 
concentrations of LLO at 37℃ and neutral pH.
Figure 3 (A) PLY inhibition activity with 10% and 30% human serum under 4℃ 20min. (B) PLY inhibition activity with 10% and 30%
human serum under 37℃ 20 min.
Figure 4. PLY inhibition activity with 10% mice serum
At temperatures above 30℃, LLO irreversibly aggregates. Our data suggest that at higher concentrations, the 
toxin aggregates at a faster rate than at lower concentrations. According to this reasoning, a higher concentration 
of toxin will lose activity more quickly than lower one. This hypothesis could be verified by measuring the 
turbidity over time of the LLO suspensions.
Future research goals
The future research goal is testing other human and murine sera to rule out donor-to-
donor variability. I will change my method to test the mice serum inhibition ability 
with LLO again. Then I will figuring out which animal model is more suitable as a 
living model to study listeriolysin O. I will test sera of Guinea pig, rabbit and gerbil 
origin in comparison to human serum. Comparing the sera will allow me to decipher 
the serum that is similar to human, with respect to listeriolysin O inhibition.
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The first step is verifying Tweten’s result of PLY. Based on his paper, exploring the property of PLY.   
Two graphs shows that the inhibited ability of human serum don’t have obvious different between two
conditions. Human serum can inhibited toxin and 30% serum is more inhibitory than 10% serum. One reason is 
that antibodies in human serum is able to inhibit toxin. However, Experiments should be repeated with 
immunoglobulin-depleted serum to evaluate the contribution of lipoproteins. According toTweten, lipoproteins in 
mouse serum can bind toxin (PLY) to inhibit toxin activity. Thus, it is necessary to test whether human serum has 
lipoprotein to inhibit toxin by removing the antibodies.  
My results shows that mice serum doesn’t inhibited toxin LLO, same as results of PLY.
Figure 2. PLY was	  incubated	  in	  PBS	  at	  37℃ for	  20	  min	  without serum. After	  20	  min	  all	  tubes	  were	  on	  the	  ice,	  and	  the	  toxin	  was	  
serially	  diluted	  in	  PBS	  or	  corresponding	  indicated	  serum	  solution	  in	  a	  96	  well	  round	  bottom	  plate	  of	  10	  ul txoin and	  150	  ul RBCs.	  The	  
plates	  were	  then	  incubated	  at	  37℃ for	  30min. Plates	  were	  centrifuge	  at	  1500	  rmp for	  5	  min.	  100	  ul of	  supernatant	  was	  transferred	  
to	  96	  flat	  bottom	  plates	  for	  optical	  density	  reading	  at	  540	  nm.	  Positive	  control:	  RBCs	  incubated	  with	  10	  ul 1%	  TX-­‐100	  used	  to	  
determine	  100%	  lysis.	  Negative	  control:	  RBCs	  incubated	  with	  10	  ul PBS	  used	  to	  determine	  0%	  lysis
The result shows that toxin PLY is stable after incubating 20 min at 37℃. Next, test the inhibited ability of
human serum with PLY.
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The result shows that LLO is temperature sensitive. It will lose lots of activity after
incubating 20 min at 37℃. This means toxin PLY is more stable than LLO under 37℃.
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Figure 4. LLO was incubated in PBS at 37℃ or 4℃ for 20 min without serum
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At the same time, I tested the inhibitory effect of human serum under different 
incubation temperatures. The complex of human serum and LLO was either incubated 
on ice for 20 minutes or in a 37℃ water bath for 20 minutes, before measuring LLO 
hemolytic activity. The results show that human serum is more active when incubated 
on ice. In addition LLO is temperature sensitive (figure 4). So I cannot incubated
serum with toxin LLO at 37℃ to test the inhibited activity, because it is hard to
determine what lead to toxin lose activity. Under ICE condition (4℃), I test the mice
serum inhibited activity with LLO.
Figure 5 (A) LLO inhibition activity with 10% and 30% human serum under 4℃ 20min. (B) LLO
inhibition activity with 10% and 30% human serum under 37℃ 20min.
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Figure 6. LLO inhibition activity
with 10% mice serum
